Cholesterol

Cholesterol ($C_{27}H_{46}O$) is a structural sterol found in all cells of the body and circulating in the blood plasma. First identified in solid form in 1769 by François Poulletier de la Salle, cholesterol is synthesized endogenously by the liver and obtained through dietary sources. While often discussed in the context of cardiovascular health, it is an indispensable biological molecule required for the structure of animal cell membranes and the production of essential biochemicals.

Clinical Benefits & Mechanism of Action

Cholesterol functions as a multifunctional lipid that orchestrates several critical physiological processes, particularly within the neurological and endocrine systems:

1.  Cell Membrane Modulation: Cholesterol embeds itself within the phospholipid bilayer of cell membranes, regulating fluidity and permeability. It supports the membrane against becoming too rigid in cold temperatures or too fluid in high temperatures, ensuring stable, normal cellular signaling.
2.  Myelin Sheath Integrity: In the central nervous system (CNS), cholesterol is a primary constituent of myelin. It acts as an electrical insulator for axons, enabling the rapid and efficient saltatory conduction of nerve impulses.
3.  Steroid Hormone Precursor: It serves as the fundamental building block for the natural synthesis of vitamin D and all endogenous steroid hormones, including glucocorticoids (cortisol), mineralocorticoids (aldosterone), and sex hormones (estrogen, progesterone, and testosterone).
4.  Bile Acid Production: The liver converts cholesterol into bile acids, which are essential for the normal emulsification and absorption of dietary fats and fat-soluble vitamins (A, D, E, and K) in the small intestine.
5.  Synaptic Plasticity: Cholesterol is vital for the normal formation and maintenance of synapses. It facilitates the clustering of receptors in “lipid rafts,” which are specialized membrane microdomains that coordinate natural signal transduction pathways.

Scientific Sources & Clinical Trials

• Promise of ANGPTL3 as a therapeutic target for controlling cholesterol levels.
• From Failure to Promise: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition in Atherosclerotic Cardiovascular Disease.
• New insights into disease-modifying factors and clinical translation for central nervous system diseases.